Health-related quality of life in adults with cystic fibrosis: The role of coping

被引:45
作者
Abbott, Janice [1 ]
Hart, Anna
Morton, Alison [2 ]
Gee, Louise [1 ]
Conway, Steven [2 ]
机构
[1] Univ Cent Lancashire, Fac Hlth, Preston PR1 2HE, Lancs, England
[2] Seacroft Hosp, Adult Cyst Fibrosis, Leeds, W Yorkshire, England
关键词
clinical trials; coping; cystic fibrosis; health-related quality of life;
D O I
10.1016/j.jpsychores.2007.08.017
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: This study examined the role of coping in explaining health-related quality of life (HRQoL) in cystic fibrosis (CF). Methods: Coping, quality of life, and clinical variables were assessed. The CF Coping Scale measures four ways of coping: optimistic acceptance, hopefulness, distraction, and avoidance. The Cystic Fibrosis Quality of Life Questionnaire (CFQoL) comprises 9 domains: physical, social, treatment, chest symptoms, emotional, body image, relationships, career, and future. Step-wise multiple regression and path analysis were used to model the associations between coping and CFQoL domains, taking into account important demographic and clinical factors. Results: One hundred and sixteen people with CF were recruited to the study. Their mean FEV1% predicted and BMI were 59.3% and 21.2 kg/m(2), respectively. Mean scores were highest for optimism and lowest for distraction coping. Coping had an inequitable influence across the CFQoL domains: it had negligible influence on domains that incorporate symptoms and aspects of physical functioning but considerable influence on psychosocial domains. Optimism and distraction were strongly associated with emotional responses, social functioning, and interpersonal relationships. A high level of optimism was associated with a better HRQoL and high levels of distraction with a poorer HRQoL. For some domains, optimism and distraction had a counterbalancing effect so the difference between them could be an important predictor of HRQoL. Conclusion: Coping has emerged as an important factor in explaining some quality-of-life domains but not others. This has important implications especially when employing HRQoL as an outcome measure in clinical trials. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:149 / 157
页数:9
相关论文
共 57 条
[1]  
Abbott J, 2003, J ROY SOC MED, V96, P42
[2]  
Abbott J, 2001, DISABIL REHABIL, V23, P315
[3]   Measuring and reporting quality of life outcomes in clinical trials in cystic fibrosis: A critical review [J].
Abbott J. ;
Hart A. .
Health and Quality of Life Outcomes, 3 (1)
[4]   Quality of life in children and adolescents with cystic fibrosis: Implications for optimizing treatments and clinical trial design [J].
Janice Abbott ;
Louise Gee .
Pediatric Drugs, 2003, 5 (1) :41-56
[5]   The benefits of optimism: A meta-analytic review of the life orientation test [J].
Andersson, G .
PERSONALITY AND INDIVIDUAL DIFFERENCES, 1996, 21 (05) :719-725
[6]   Sickle cell disease: Pain, coping and quality of life in a study of adults in the UK [J].
Anie, KA ;
Steptoe, A ;
Bevan, DH .
BRITISH JOURNAL OF HEALTH PSYCHOLOGY, 2002, 7 :331-344
[7]   Gender differences in health-related quality of life of adolescents with cystic fibrosis [J].
Arrington-Sanders, Renata ;
Yi, Michael S. ;
Tsevat, Joel ;
Wilmott, Robert W. ;
Mrus, Joseph M. ;
Britto, Maria T. .
HEALTH AND QUALITY OF LIFE OUTCOMES, 2006, 4 (1)
[8]   Rethinking the role of positive affect in self-regulation [J].
Aspinwall, LG .
MOTIVATION AND EMOTION, 1998, 22 (01) :1-32
[9]   What you see may not be what you get: A brief, nontechnical introduction to overfitting in regression-type models [J].
Babyak, MA .
PSYCHOSOMATIC MEDICINE, 2004, 66 (03) :411-421
[10]   Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis [J].
Britto, MT ;
Kotagal, UR ;
Hornung, RW ;
Atherton, HD ;
Tsevat, J ;
Wilmott, RW .
CHEST, 2002, 121 (01) :64-72